🇺🇸 Theracurmin HP in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 10

Most-reported reactions

1. Adverse Drug Reaction — 1 report (10%)
2. Anxiety — 1 report (10%)
3. Bladder Disorder — 1 report (10%)
4. Cardiac Disorder — 1 report (10%)
5. Drug Ineffective — 1 report (10%)
6. Hepatic Steatosis — 1 report (10%)
7. Muscle Spasms — 1 report (10%)
8. Muscle Twitching — 1 report (10%)
9. Nausea — 1 report (10%)
10. Sleep Disorder — 1 report (10%)

Source database →

Frequently asked questions

Is Theracurmin HP approved in United States?

Theracurmin HP does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Theracurmin HP in United States?

Richard Bedlack, M.D., Ph.D. is the originator. The local marketing authorisation holder may differ — check the official source linked above.